Recent data have indicated the pathophysiological role of IL-17 in Graves' ophthalmopathy development due to the presence of elevated IL-17 and the correlation of IL-17 with clinical activity in GO patients [21]. This evidence concerns the gene IL17A and geroderma osteodysplastica.